Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-12-28
1994-08-16
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548183, C07D27734, A01K 31425
Patent
active
053388550
ABSTRACT:
Compounds of formula (I): ##STR1## (wherein: R.sup.1 is alkyl; R.sup.2 and R.sup.3 are each alkyl or alkoxy, or R.sup.2 and R.sup.3 together form an optionally substituted benzene ring and, when R.sup.2 and R.sup.3 together form said benzene ring, R.sup.1 is hydrogen, halogen or alkyl; R.sup.4 and R.sup.5 both represent hydrogen, or together represent a single carbon-carbon bond; W is a single bond or alkylene; and Z is a hydrogen atom or a cation) have valuable therapeutic and prophylactic activities, including anti-diabetic activities.
REFERENCES:
patent: 4572912 (1986-02-01), Yoshioka et al.
patent: 4725010 (1988-02-01), Meguro
patent: 5120754 (1992-06-01), Clark
patent: 5130379 (1992-07-01), Clark
patent: 5143930 (1992-09-01), Yoshioka et al.
Aizawa Yuichi
Fujita Takashi
Horikoshi Hiroyoshi
Kanai Tsutomu
Nishi Takahide
Gerstl Robert
Sankyo Company Limited
LandOfFree
Thiazolidine compounds containing a quinone group, their prepara does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazolidine compounds containing a quinone group, their prepara, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolidine compounds containing a quinone group, their prepara will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-953118